Skip to content

Platelet Rich Plasma Testis Treatment for Infertile Men

Platelet Rich Plasma Testis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05479474
Enrollment
10
Registered
2022-07-29
Start date
2023-01-18
Completion date
2026-12-31
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Azoospermia, Male Infertility, Nonobstructive Azoospermia

Brief summary

Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.

Interventions

BIOLOGICALPlatelet rich plasma

Patients will undergo a blood draw (12 tsp) to prepare the PRP infusion. The use of a centrifuge and an Arteriocyte Magellan kit are necessary for the PRP preparation. After injection of local anesthesia, PRP will be injected into each testicle. * On the third month after the testicular PRP procedure, a TESE will be performed * If the procedure is successful a new IVF cycle using the sperm procured from the procedure will be done.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men over the age of 18 diagnosed with NOA and at least one failed TESE, negative mapping or negative biopsy

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
sperm present3 months after PRP injectionA TESE procedure will be performed to determine if sperm are present

Countries

United States

Contacts

Primary ContactSatvir Basran
sbasran@stanford.edu650-723-0948

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026